MiniMed completes separation from Medtronic, becoming an independent company
MiniMed separated from its parent Medtronic after completing an exchange offer for its shares, marking the diabetes company's first day as a standalone entity focused on advancing its therapies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed